Compounder Nets Warning Letter for Insanitary, cGMP Issues

Drug Industry Daily
A A
The FDA served Auro Pharmacies — a California-based compounder — with a warning letter after the agency determined the firm produced products under insanitary conditions.

To View This Article:

Login

Subscribe To Drug Industry Daily